Exports of Ayush and herbal products for the first six months of the current fiscal has reported a 10.34 per cent growth, as ...
The recent amendments brought by the Union Ministry of Ayush to the Drugs and Cosmetics Rules, 1945 are significant, as they introduce new regulatory requirements for the manufacturing and sale of ...
Centre notifies rules for recruitment of medical device officers in CDSCO: Gireesh Babu, New Delhi Monday, November 11, 2024, 08:00 Hrs [IST] In an effort to strengthen the regula ...
SpringWorks to present long-term efficacy and safety data from phase 3 DeFi trial of Ogsiveo in adults with desmoid tumours at CTOS 2024 meeting: Stamford, Connecticut Saturday, N ...
Dizal seeks US FDA approval for sunvozertinib to treat relapsed or refractory NSCLC with EGFR Exon 20 insertion mutations: Shanghai, China Saturday, November 9, 2024, 17:00 Hrs [I ...
Serres Group receives €1.8 million research grant from Business Finland: Espoo, Finland Saturday, November 9, 2024, 16:00 Hrs [IST] Serres has been granted a substantial researc ...
Adaptive Biotechnologies get expanded medicare coverage of clonoSEQ for assessing measurable residual disease in mantle cell lymphoma: Seattle Saturday, November 9, 2024, 15:00 Hr ...
Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and NEC Corporation, a leader in IT, network and AI technologies, announced 24.1 month ...
As part of the National Pharmacy Week (NPW) celebration, the Kerala Private Pharmacist Association (KPPA) is organizing a high-impact webinar series from November 17th to 23rd, connected by the common ...
The Subject Expert Committee (SEC), which advises the national drug regulator on matters related to approval of new drugs and medical devices and clinical trials, has recommended grant of market ...
Indian pharma and biotech companies are confident that under the new US President Donald Trump, its strengths in high quality generics manufacture and export will continue to command respect. This ...